Search Results - Underbayev, Chingiz
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL) by Kasar, Siddha, Underbayev, Chingiz, Hassan, Moinuddin, Ilev, Ilko, Degheidy, Heba, Bauer, Steven, Marti, Gerald, Lutz, Carol, Raveche, Elizabeth, Batish, Mona
Published 2016Text -
8
Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia by Underbayev, Chingiz, Kasar, Siddha, Ruezinsky, William, Degheidy, Heba, Schneider, Joel Solomon, Marti, Gerald, Bauer, Steven R., Fraidenraich, Diego, Lightfoote, Marilyn M., Parashar, Vijay, Raveche, Elizabeth, Batish, Mona
Published 2016Text -
9
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era by Robinson, Hannah R., Qi, Junpeng, Cook, Erika M., Nichols, Cydney, Dadashian, Eman L., Underbayev, Chingiz, Herman, Sarah E. M., Saba, Nakhle S., Keyvanfar, Keyvan, Sun, Clare, Ahn, Inhye E., Baskar, Sivasubramanian, Rader, Christoph, Wiestner, Adrian
Published 2018Text -
10
MALT1 inhibition is efficacious in both naïve and ibrutinib-resistant chronic lymphocytic leukemia by Saba, Nakhle S., Wong, Deanna H., Tanios, Georges, Iyer, Jessica R., Lobelle-Rich, Patricia, Dadashian, Eman L., Liu, Delong, Fontan, Lorena, Flemington, Erik K., Nichols, Cydney M., Underbayev, Chingiz, Safah, Hana, Melnick, Ari, Wiestner, Adrian, Herman, Sarah E. M.
Published 2017Text -
11
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma by Saba, Nakhle S., Liu, Delong, Herman, Sarah E. M., Underbayev, Chingiz, Tian, Xin, Behrend, David, Weniger, Marc A., Skarzynski, Martin, Gyamfi, Jennifer, Fontan, Lorena, Melnick, Ari, Grant, Cliona, Roschewski, Mark, Navarro, Alba, Beà, Sílvia, Pittaluga, Stefania, Dunleavy, Kieron, Wilson, Wyndham H., Wiestner, Adrian
Published 2016Text -
12
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia by Ahn, Inhye E., Underbayev, Chingiz, Albitar, Adam, Herman, Sarah E. M., Tian, Xin, Maric, Irina, Arthur, Diane C., Wake, Laura, Pittaluga, Stefania, Yuan, Constance M., Stetler-Stevenson, Maryalice, Soto, Susan, Valdez, Janet, Nierman, Pia, Lotter, Jennifer, Xi, Liqiang, Raffeld, Mark, Farooqui, Mohammed, Albitar, Maher, Wiestner, Adrian
Published 2017Text -
13
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy by Landau, Dan A., Sun, Clare, Rosebrock, Daniel, Herman, Sarah E. M., Fein, Joshua, Sivina, Mariela, Underbayev, Chingiz, Liu, Delong, Hoellenriegel, Julia, Ravichandran, Sarangan, Farooqui, Mohammed Z. H., Zhang, Wandi, Cibulskis, Carrie, Zviran, Asaf, Neuberg, Donna S., Livitz, Dimitri, Bozic, Ivana, Leshchiner, Ignaty, Getz, Gad, Burger, Jan A., Wiestner, Adrian, Wu, Catherine J.
Published 2017Text -
14
MARCKS affects cell motility and response to BTK inhibitors in CLL by Beckmann, Laura, Berg, Valeska, Dickhut, Clarissa, Sun, Clare, Merkel, Olaf, Bloehdorn, Johannes, Robrecht, Sandra, Seifert, Marc, da Palma Guerreiro, Alexandra, Claasen, Julia, Loroch, Stefan, Oliverio, Matteo, Underbayev, Chingiz, Vaughn, Lauren, Thomalla, Daniel, Hülsemann, Malte F., Tausch, Eugen, Fischer, Kirsten, Fink, Anna Maria, Eichhorst, Barbara, Sickmann, Albert, Wendtner, Clemens M., Stilgenbauer, Stephan, Hallek, Michael, Wiestner, Adrian, Zahedi, René P., Frenzel, Lukas P.
Published 2021Text